Author = Mahdi Behdani
Number of Articles: 7
Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate

Volume 25, Issue 3, March 2022, Pages 313-319

10.22038/ijbms.2022.62522.13834

Akbar Oghalaei; Feriedon Mahbudi; Fatemeh Rahimi Jamnani; Somayeh Piri-Gavgani; Fatemeh Kazemi-Lomedasht; Aida Hassanzadeh-Eskafi; Delavar Shahbazzadeh; Ahmad Adeli; Yeganeh Talebkhan; Mahdi Behdani

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin

Volume 25, Issue 1, January 2022, Pages 27-31

10.22038/ijbms.2021.54293.12195

Mohammad Hosseininejad-Chafi; Ehsan Alirahimi; Behzad Ramezani; Akbar Oghalaei; Nazli Sotoudeh; Hajarsadat Ghaderi; Fatemeh Kazemi-Lomedasht; Mahdi Habibi-Anbouhi; Reza Moazzami; Mahdi Behdani

Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein

Volume 24, Issue 12, December 2021, Pages 1726-1733

10.22038/ijbms.2021.58542.13003

Hajarsadat Ghaderi; Zahra Noormohammadi; Mahdi Habibi-Anbouhi; Fatemeh Kazemi-Lomedasht; Mahdi Behdani

Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)

Volume 24, Issue 9, September 2021, Pages 1264-1271

10.22038/ijbms.2021.57774.12851

Nazli Sotoudeh; Zahra Noormohammadi; Mahdi Habibi-Anbouhi; Fatemeh Kazemi-Lomedasht; Mahdi Behdani

In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies

Volume 23, Issue 10, October 2020, Pages 1335-1339

10.22038/ijbms.2020.47782.11000

Nastaran Mohseni; Reyhaneh Roshan; Shamsi Naderi; Mahdi Behdani; Fatemeh Kazemi-Lomedasht

A comparative study on the equine and camelid antivenoms upon cardiovascular changes induced with Hemiscorpius lepturus venom in rats

Volume 22, Issue 12, December 2019, Pages 1440-1444

10.22038/ijbms.2019.14052

Hossein Fatemikia; Mostafa Kamyab; Ali Movahed; Mehdi Sadeghi; Euikyung Kim; Mahdi Behdani; Naser Mohammadpour; Mehrnaz Shahrivar; Ramin Seyedian

Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody

Volume 21, Issue 9, September 2018, Pages 884-888

10.22038/ijbms.2018.26191.6432

Farideh Ranjibar; Mahdi Habibi-Anbouhi; Fatemeh Kazemi-Lomedasht; Seyed Hamid Aghaee-Bakhtiyari; Ehsan Alirahimi; Mahdi Behdani

Iranian Journal of Basic Medical Sciences

Journal Archive